±è³²ÈÆ

  • Áø·á°ú

    ³»ºÐºñ³»°ú

  • Àü¹®Áø·áºÐ¾ß

    ³»ºÐºñÁúȯ, ´ç´¢º´, °©»ó¼± ±â´ÉÇ×ÁøÁõ, °©»ó¼± ±â´ÉÀúÇÏÁõ, °©»ó¼±¾Ï

  • ´ã´çŬ¸®´Ð

  • °ü·Ã¼¾ÅÍ

    ´ç´¢¼¾ÅÍ , °©»ó¼±¼¾ÅÍ , ¾Ïº´¿ø ȨÆäÀÌÁö

±è³²ÈÆ

±è³²ÈÆ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
³»ºÐºñ³»°ú - -
Á¾ÀÏ
¿ÀÀü
- - ³»ºÐºñÁúȯ, ´ç´¢º´, °©»ó¼± ±â´ÉÇ×ÁøÁõ, °©»ó¼± ±â´ÉÀúÇÏÁõ, °©»ó¼±¾Ï
´ç´¢¼¾ÅÍ - - - - - - ³»ºÐºñÁúȯ, ´ç´¢º´, °©»ó¼± ±â´ÉÇ×ÁøÁõ, °©»ó¼± ±â´ÉÀúÇÏÁõ, °©»ó¼±¾Ï
°©»ó¼±¼¾ÅÍ - - -
¿ÀÈÄ
- - ³»ºÐºñÁúȯ, ´ç´¢º´, °©»ó¼± ±â´ÉÇ×ÁøÁõ, °©»ó¼± ±â´ÉÀúÇÏÁõ, °©»ó¼±¾Ï

±è³²ÈÆ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  •  ~  2004  :  °í·Á´ëÇб³ Àǰú´ëÇÐ Á¹¾÷
  •  ~  2009  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¼®»ç
  •  ~  2015  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ´ëÇпø ¹Ú»ç

°æ·Â

more
  • 2012  ~  2013  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ³»ºÐºñ³»°ú ÀÓ»ó°­»ç
  • 2014  ~  2016  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ³»ºÐºñ³»°ú ÀÓ»óÁ¶±³¼ö
  • 2016  ~  2018  :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ³»ºÐºñ³»°ú Á¶±³¼ö
  • 2019  ~  2020  :  UCSD ¿¬¼ö
  • 2018  ~   :  °í·Á´ëÇб³ ¾È¾Ïº´¿ø ³»ºÐºñ³»°ú ºÎ±³¼ö

¼ö»ó³»¿ª

more
  • 2013  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ±³¿ìȸ Çг»ÁöºÎ ¿ì¼ö ³í¹®»ó
  • 2015  :  ´ëÇÑ´ç´¢º´ÇÐȸ Ãá°èÇмú´ëȸ ¿ì¼ö Æ÷½ºÅÍ ±¸¿¬»ó
  • 2017  :  Seoul International Congress of Endocrinology and Metabolism 2017 ¿ì¼ö ±¸¿¬»ó
  • 2017  :  ´ëÇѳ»ºÐºñÇÐȸ ¿¬±¸»ó
  • 2017  :  ´ëÇѳ»ºÐºñÇÐȸ EnM Çмú»ó
  • 2018  :  Seoul International Congress of Endocrinology and Metabolism 2018 ¿ì¼ö ±¸¿¬»ó
  • 2018  :  Diabetes & Metabolism Journal ¿ì¼ö³í¹®»ó
  • 2018  :  ´ëÇѳ»ºÐºñÇÐȸ ½ÅÁø¿¬±¸ÀÚ»ó
  • 2019  :  Diabetes & Metabolism Journal ¿ì¼ö³í¹®»ó
  • 2020  :  ´ëÇÑ´ç´¢º´ÇÐȸ Young Investigator Award (Çѵ¶Çмú»ó)
  • 2021  :  Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ JLA ¿ì¼ö³í¹®»ó
  • 2021  :  DMJ °ø·Î»ó

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇÑ´ç´¢º´ÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѳ»ºÐºñÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѺñ¸¸ÇÐȸ Á¤È¸¿ø
  •  ~   :  Asian Association for the Study of Diabetes Á¤È¸¿ø
  •  ~   :  ¹Ì±¹ ´ç´¢º´ ÇÐȸ Á¤È¸¿ø
  • 2017 .01  ~  2018 .12  :  ´ëÇѳ»ºÐºñÇÐȸ ÇмúÀ§¿øÈ¸ °£»ç
  • 2018 .01  ~  2019 .12  :  ´ëÇÑ´ç´¢º´ÇÐȸ ±âȹÀ§¿øÈ¸ °£»ç
  • 2020 .01  ~   :  ´ëÇÑ´ç´¢º´ÇÐȸ Áø·áÁöħÀ§¿øÈ¸ À§¿ø
  • 2019 .01  ~   :  ´ëÇѺñ¸¸ÇÐȸ ¿¬±¸À§¿øÈ¸ À§¿ø
  • 2021 .01  ~   :  ´ëÇѳ»ºÐºñÇÐȸ ±âȹÀ§¿øÈ¸ °£»ç
  • 2021 .01  ~   :  Çѱ¹ÁöÁúµ¿¸Æ°æÈ­ÇÐȸ °£ÇàÀ§¿øÈ¸ À§¿ø
  • 2021 .01  ~   :  ´ëÇѺñ¸¸ÇÐȸ ITÀ¶ÇÕ ´ë»çÁõÈıº Ä¡·áÀ§¿øÈ¸ À§¿ø
  • 2022 .01  ~   :  ´ëÇÑ´ç´¢º´ÇÐȸ ¼ö¼®ºÎÃѹ«

³í¹®

more
  • [SCI] (A pooled analysis of 29 patients with fulminant type 1 diabetes in Korea: A comparison with a nationwide survey in Japan)
  • [SCI] (A patient with micropapillary thyroid carcinoma and macronodular lung metastasis: Stable disease for eight years without treatment)
  • [SCI] (Depression is associated with sarcopenia, not central obesity, in elderly Korean men)
  • [SCI] (Short sleep duration combined with obstructive sleep apnea is associated with visceral obesity in Korean adults)
  • [SCI] (Effect of cilostazol on arterial stiffness and vascular adhesion molecules in type 2 diabetic patients with metabolic syndrome: a randomised, double-blind, placebo-controlled, crossover trial)
  • [±¹³»³í¹®] DPP-4 ¾ïÁ¦Á¦ÀÇ ºñ±³(Comparison of DPP-4 inhibitors)
  • [SCI] (Clinical and Metabolic Factors Associated with Development and Regression of Nonalcoholic Fatty Liver Disease in Nonobese Subjects)
  • [SCI] (Age-related differences in diabetes care outcomes in Korea: a retrospective cohort study)
  • [SCI] (Body Mass Index and Mortality in the General Population and in Subjects with Chronic Disease in Korea: A Nationwide Cohort Study (2002-2010))
  • [SCI] (Vitamin D status and associated metabolic risk factors among North Korean refugees in South Korea: a cross-sectional study)
  • [±¹³»³í¹®] (Editorial: Cancer survivors at risk of metabolic disorder)
  • [±¹³»³í¹®] (Primary hyperparathyroidism with extensive brown tumors and multiple fractures in a 20-year-old woman)
  • [±¹³»³í¹®] (Metastatic papillary thyroid cancers with malignant pleural effusion aggravated during thyroid hormone withdrawal for radioiodine therapy)
  • [SCI] (Development of Spexin-based Human Galanin Receptor Type II-Specific Agonists with Increased Stability in Serum and Anxiolytic Effect in Mice)
  • [SCI] (Relative and combined effects of socioeconomic status and diabetes on mortality: A nationwide cohort study.)
  • [SCI] (Letter: Clinical Course and Risk Factors of Diabetic Retinopathy in Patients with Type 2 Diabetes Mellitus in Korea (Diabetes Metab J 2016;40:482-93).)
  • [SCI] (Increased Vascular Disease Mortality Risk in Prediabetic Korean Adults Is Mainly Attributable to Ischemic Stroke)
  • [±¹³»³í¹®] (Lessons from recent cardiovascular outcome trials of type 2 diabetes)
  • [±¹³»³í¹®] (Effects of Vildagliptin or Pioglitazone on Glycemic Variability and Oxidative Stress in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Monotherapy: A 16-Week, Randomised, Open Label, Pilot Study)
  • [SCI] (Determinants of Long-Term Durable Glycemic Control in New-Onset Type 2 Diabetes Mellitus)
  • [±¹³»³í¹®] Dipeptidyl Pepdiase-4 ¾ïÁ¦Á¦¿Í Sodium Glucose Cotransporter 2 ¾ïÁ¦Á¦ÀÇ »õ·Î¿î ¾ÈÀü¼º ÀÌÀ¯: ¾î¶»°Ô ÇØ¼®Çϰí Áø·áÇöÀå¿¡ Àû¿ëÇÒ °ÍÀΰ¡?
  • [SCI] (Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model)
  • [SCI] (Dipeptidyl peptidase-4 inhibitor use and risk of diabetic retinopathy: A population-based study)
  • [SCI] (10-Year Mortality Trends for Adults with and without Diabetes Mellitus in South Korea, 2003 to 2013.)
  • [SCI] (Efficacy and tolerability of novel triple combination therapy in drug-naive patients with type 2 diabetes from the TRIPLE-AXEL trial: protocol for an open-label randomised controlled trial)
  • [SCI] (A novel central adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality: proposal and validation)
  • [SCI] (Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study)
  • [±¹³»³í¹®] (Effects of Dipeptidyl Peptidase-4 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis)
  • [SCI] (Diabetes Mellitus, Still Major Threat to Mortality from Various Causes)
  • [SCI] (Use of fenofibrate on cardiovascular outcomes in statin users with metabolic syndrome: propensity matched cohort study)
  • [SCI] (Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Renal Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials)
  • [SCI] (Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction)
  • [SCI] (Weight-adjusted waist index reflects fat and muscle mass in the opposite direction in older adults)
  • [SCI] (Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study)
  • [SCIE] (Comparative Renal Effects of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Cotransporter 2 Inhibitors on Individual Outcomes in Patients with Type 2 Diabetes: A Systematic Review and Network Meta-Analysis)
  • [SCIE] (Use of Renin-Angiotensin-Aldosterone System Inhibitors and Severe COVID-19 Outcomes in Patients with Hypertension: A Nationwide Cohort Study)
  • [SCI] (Cardiovascular risks associated with calcium supplementation in patients with osteoporosis: a nationwide cohort study.)
  • [SCI] (Remission of type 2 diabetes after gastrectomy for gastric cancer: diabetes prediction score)
  • [SCI] (2021 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association)
  • [SCI] (Young-onset type 2 diabetes in South Korea: a review of the current status and unmet need)
  • [SCI] (Metabolically unhealthy individuals, either with obesity or not, have a higher risk of critical coronavirus disease 2019 outcomes than metabolically healthy individuals without obesity)
  • [±¹³»³í¹®] (Statin Therapy and the Risk of Osteoporotic Fractures in Patients with Metabolic Syndrome: a Nested Case-Control Study)
  • [SCI] (How Can We Adopt the Glucose Tolerance Test to Facilitate Predicting Pregnancy Outcome in Gestational Diabetes Mellitus?)

Àú¼­

more
  • ´ç´¢º´ÇÐ ±³°ú¼­ (5ÆÇ)

ÃÖÁ¾¼öÁ¤ÀÏ : 2021.11.18